DPYSL2 and Alzheimer disease: Interestingly, CRMP2 phosphorylation has been found to be increased in AD, suggesting that CRMP2 phosphorylation is associated with Aβ pathology, and that CRMP2 dysregulation may be one mechanism underlying axonopathy and neurite degeneration [16, 17].